BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 1766668)

  • 1. p53 transgenic mice: accelerated erythroleukemia induction by Friend virus.
    Lavigueur A; Bernstein A
    Oncogene; 1991 Dec; 6(12):2197-201. PubMed ID: 1766668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of p53 tumor suppressor function is required for in vivo progression of Friend erythroleukemia.
    Prasher JM; Elenitoba-Johnson KS; Kelley LL
    Oncogene; 2001 May; 20(23):2946-55. PubMed ID: 11420707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insertional inactivation of the p53 gene during friend leukemia: a new strategy for identifying tumor suppressor genes.
    Ben-David Y; Lavigueur A; Cheong GY; Bernstein A
    New Biol; 1990 Nov; 2(11):1015-23. PubMed ID: 2101628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of the p53 oncogene by internal deletion or retroviral integration in erythroleukemic cell lines induced by Friend leukemia virus.
    Ben David Y; Prideaux VR; Chow V; Benchimol S; Bernstein A
    Oncogene; 1988 Aug; 3(2):179-85. PubMed ID: 2842714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53-independent tumor growth and in vitro cell survival for F-MuLV-induced erythroleukemias.
    Howard J; Ung Y; Adachi D; Ben-David Y
    Cell Growth Differ; 1996 Dec; 7(12):1651-60. PubMed ID: 8959333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of p53 in F-MuLV induced-erythroleukemias accelerates the acquisition of mutational events that confers immortality and growth factor independence.
    Wong KS; Li YJ; Howard J; Ben-David Y
    Oncogene; 1999 Sep; 18(40):5525-34. PubMed ID: 10523829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Friend virus induced murine erythroleukaemia: the p53 locus.
    Johnson P; Benchimol S
    Cancer Surv; 1992; 12():137-51. PubMed ID: 1638545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bcl-2 expression in F-MuLV-induced erythroleukemias: a role for the anti-apoptotic action of Bcl-2 during tumor progression.
    Howard JC; Li Q; Chu W; Zochodne B; Kapoor M; Ung Y; Rosen K; Ben-David Y
    Oncogene; 2001 Apr; 20(18):2291-300. PubMed ID: 11402324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damage.
    Kelley LL; Hicks GG; Hsieh FF; Prasher JM; Green WF; Miller MD; Eide EJ; Ruley HE
    Oncogene; 1998 Sep; 17(9):1119-30. PubMed ID: 9764822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Friend virus-induced erythroleukemias: a unique and well-defined mouse model for the development of leukemia.
    Lee CR; Cervi D; Truong AH; Li YJ; Sarkar A; Ben-David Y
    Anticancer Res; 2003; 23(3A):2159-66. PubMed ID: 12894591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rearrangements of the Pim-1, c-myc, and p53 genes in Friend helper virus-induced mouse erythroleukemias.
    Dreyfus F; Sola B; Fichelson S; Varlet P; Charon M; Tambourin P; Wendling F; Gisselbrecht S
    Leukemia; 1990 Aug; 4(8):590-4. PubMed ID: 2143796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal order and functional analysis of mutations within the Fli-1 and p53 genes during the erythroleukemias induced by F-MuLV.
    Howard JC; Yousefi S; Cheong G; Bernstein A; Ben-David Y
    Oncogene; 1993 Oct; 8(10):2721-9. PubMed ID: 8378083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Fli-1 proto-oncogene, involved in erythroleukemia and Ewing's sarcoma, encodes a transcriptional activator with DNA-binding specificities distinct from other Ets family members.
    Zhang L; Lemarchandel V; Romeo PH; Ben-David Y; Greer P; Bernstein A
    Oncogene; 1993 Jun; 8(6):1621-30. PubMed ID: 8502483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spi-1 transgenic mice develop a clonal erythroleukemia which does not depend on p53 mutation.
    Barnache S; Wendling F; Lacombe C; Denis N; Titeux M; Vainchenker W; Moreau-Gachelin F
    Oncogene; 1998 Jun; 16(23):2989-95. PubMed ID: 9662331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spi-1 oncogene activation in Rauscher and Friend murine virus-induced acute erythroleukemias.
    Moreau-Gachelin F; Ray D; de Both NJ; van der Feltz MJ; Tambourin P; Tavitian A
    Leukemia; 1990 Jan; 4(1):20-3. PubMed ID: 2153262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protooncogene expression in normal, preleukemic, and leukemic murine erythroid cells and its relationship to differentiation and proliferation.
    Robert-Lézénès J; Meneceur P; Ray D; Moreau-Gachelin F
    Cancer Res; 1988 Jul; 48(14):3972-6. PubMed ID: 3164254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of Friend leukemia virus.
    Ikawa Y
    Leukemia; 1997 Apr; 11 Suppl 3():152-4. PubMed ID: 9209327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the erythropoietin gene in the majority of F-MuLV-induced erythroleukemias results in growth factor independence and enhanced tumorigenicity.
    Howard JC; Berger L; Bani MR; Hawley RG; Ben-David Y
    Oncogene; 1996 Apr; 12(7):1405-15. PubMed ID: 8622856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and mapping of a common proviral integration site Fli-1 in erythroleukemia cells induced by Friend murine leukemia virus.
    Ben-David Y; Giddens EB; Bernstein A
    Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1332-6. PubMed ID: 2304901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection for loss of p53 function in T-cell lymphomagenesis is alleviated by Moloney murine leukemia virus infection in myc transgenic mice.
    Baxter EW; Blyth K; Cameron ER; Neil JC
    J Virol; 2001 Oct; 75(20):9790-8. PubMed ID: 11559812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.